Shepherd Financial Partners LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,714 shares of the healthcare conglomerate’s stock after purchasing an additional 309 shares during the quarter. Shepherd Financial Partners LLC’s holdings in UnitedHealth Group were worth $2,882,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Kraft Davis & Associates LLC grew its position in UnitedHealth Group by 3.4% in the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock valued at $294,000 after acquiring an additional 19 shares in the last quarter. Secure Asset Management LLC grew its position in UnitedHealth Group by 0.8% in the third quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock valued at $1,238,000 after acquiring an additional 19 shares in the last quarter. Iron Horse Wealth Management LLC grew its position in UnitedHealth Group by 1.6% in the third quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after acquiring an additional 19 shares in the last quarter. Bensler LLC grew its position in UnitedHealth Group by 0.3% in the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after acquiring an additional 19 shares in the last quarter. Finally, Addison Advisors LLC grew its position in UnitedHealth Group by 9.0% in the second quarter. Addison Advisors LLC now owns 241 shares of the healthcare conglomerate’s stock valued at $116,000 after acquiring an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 85.69% of the company’s stock.
Insider Activity at UnitedHealth Group
In related news, Director Stephen J. Hemsley sold 66,081 shares of the stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the completion of the transaction, the director now directly owns 635,528 shares of the company’s stock, valued at $349,788,255.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.35% of the company’s stock.
UnitedHealth Group Trading Up 1.5 %
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. The business had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. UnitedHealth Group’s quarterly revenue was up 14.1% on a year-over-year basis. During the same period last year, the company earned $5.34 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 27.84 earnings per share for the current year.
Analyst Upgrades and Downgrades
UNH has been the subject of a number of recent analyst reports. Stephens decreased their price target on shares of UnitedHealth Group from $615.00 to $605.00 and set an “overweight” rating for the company in a research report on Tuesday, January 16th. UBS Group upgraded UnitedHealth Group from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $520.00 to $640.00 in a research note on Monday, October 16th. Truist Financial restated a “buy” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research note on Thursday, November 30th. Morgan Stanley reduced their price objective on UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating on the stock in a research note on Monday, October 23rd. Finally, StockNews.com cut UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 21st. One investment analyst has rated the stock with a sell rating, one has given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $575.79.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- Technology Stocks Explained: Here’s What to Know About Tech
- What are specialty REITs? How to invest in them
- How to Calculate Stock Profit
- Miso Robotics stock: Is an IPO coming soon?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Insiders are selling these hot stocks on track for higher prices
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.